Moleculin Biotech risks Nasdaq delisting after shares stay below $1 bid threshold
Moleculin Biotech received a Nasdaq staff determination letter on Sept. 15, 2026, flagging noncompliance with the $1 minimum bid rule. Shares closed below $1 for 30 straight business days from July 31, 2026 through Sept. 11, 2026. Nasdaq denied the standard 180-day cure period due to a 1-for-25 reverse split on Dec. 1,